Literature DB >> 22930106

[Neurological manifestations of vasculitis and primary central nervous system vasculitis].

T Magnus1, A Melms, I Kötter, J U Holle.   

Abstract

Neurologic complications of vasculitis occur frequently in the form of either peripheral neuropathy or manifestations within the central nervous system (CNS). Primary vasculitis of the CNS is characterized by central nervous system manifestations only with no evidence of systemic disease manifestations. Large vessel vasculitis is particularly associated with central nervous system complications, such as ischemic cerebral infarcts whereas medium size, e.g. polyarteritis nodosa and small vessel vasculitis, e.g. antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis manifest with peripheral neuropathies and central nervous system complications. The same also holds true for Behçet's disease which affects both large, medium and small sized arteries and veins. Due to the severity of nervous system manifestations a highly potent immunosuppressive therapy (e.g. cyclophosphamide and glucocorticoids) is usually required for remission induction. Virus-associated vasculitis (e.g. hepatitis C-associated cryoglobulinemic vasculitis) should receive antiviral therapy as first line treatment. Chronic damage is frequent in spite of swift initiation of immunosuppressive treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22930106     DOI: 10.1007/s00393-012-0957-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  45 in total

1.  Giant cell arteritis: Involvement of intracranial arteries.

Authors:  Carlo Salvarani; Caterina Giannini; Dylan V Miller; Gene Hunder
Journal:  Arthritis Rheum       Date:  2006-12-15

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

Review 3.  Neurological involvement in Wegener's granulomatosis.

Authors:  Julia U Holle; Wolfgang L Gross
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 4.  Primary angiitis of the CNS.

Authors:  Rula A Hajj-Ali; Aneesh B Singhal; Susanne Benseler; Eamonn Molloy; Leonard H Calabrese
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

5.  Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

Authors:  Christian Pagnoux; Raphaèle Seror; Corneliu Henegar; Alfred Mahr; Pascal Cohen; Véronique Le Guern; Boris Bienvenu; Luc Mouthon; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2010-02

6.  Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging.

Authors:  T A Bley; O Weiben; M Uhl; P Vaith; D Schmidt; K Warnatz; M Langer
Journal:  Arthritis Rheum       Date:  2005-08

7.  CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

Authors:  Ina Kötter; Ilhan Günaydin; Marion Batra; Reinhard Vonthein; Nicole Stübiger; Gerhard Fierlbeck; Arthur Melms
Journal:  Clin Rheumatol       Date:  2005-11-01       Impact factor: 2.980

8.  Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

Authors:  Ravi Suppiah; Robert D M Hadden; Rajbir Batra; Nigel K Arden; Michael P Collins; Loic Guillevin; David R W Jayne; Raashid A Luqmani
Journal:  Rheumatology (Oxford)       Date:  2011-09-02       Impact factor: 7.580

9.  Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?

Authors:  Kathleen Maksimowicz-McKinnon; Tiffany M Clark; Gary S Hoffman
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

10.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15
View more
  3 in total

1.  Freiburg neuropathology case conference: contrast-enhancing white matter lesion adjacent to the lateral ventricle.

Authors:  C A Taschner; S Brendecke; M Trippel; A Keuler; M Prinz
Journal:  Clin Neuroradiol       Date:  2013-05-12       Impact factor: 3.649

2.  Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.

Authors:  Olga Vera-Lastra; Jesús Sepúlveda-Delgado; María del Pilar Cruz-Domínguez; Gabriela Medina; Moisés Casarrubias-Ramírez; Luis E Molina-Carrión; Luis F Pineda-Galindo; Arturo Olvera-Acevedo; Claudia Hernández-Gonzalez; Luis J Jara
Journal:  Clin Rheumatol       Date:  2014-11-27       Impact factor: 2.980

Review 3.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.